These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18438831)

  • 1. Link between tumor necrosis factor inhibitors and onset of uveitis: comment on the article by Lim et al.
    Sheane BJ; Howard D; Doran MF; Cunnane G
    Arthritis Rheum; 2008 May; 58(5):1554; author reply 1556-7. PubMed ID: 18438831
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor inhibitors and uveitis: comment on the article by Lim et al.
    Sfikakis PP; Markomichelakis N
    Arthritis Rheum; 2008 May; 58(5):1554-5; author reply 1556-7. PubMed ID: 18438832
    [No Abstract]   [Full Text] [Related]  

  • 3. Uveitis following the use of tumor necrosis factor alpha inhibitors: comment on the article by Lim et al.
    Scrivo R; Spadaro A; Spinelli FR; Valesini G
    Arthritis Rheum; 2008 May; 58(5):1555-6; author reply 1556-7. PubMed ID: 18438848
    [No Abstract]   [Full Text] [Related]  

  • 4. Uveitis and tumour necrosis factor blockade in ankylosing spondylitis.
    Coates LC; McGonagle DG; Bennett AN; Emery P; Marzo-Ortega H
    Ann Rheum Dis; 2008 May; 67(5):729-30. PubMed ID: 18408116
    [No Abstract]   [Full Text] [Related]  

  • 5. Onset of psoriasis during treatment with TNF-{alpha} antagonists: a report of 3 cases.
    Ubriani R; Van Voorhees AS
    Arch Dermatol; 2007 Feb; 143(2):270-2. PubMed ID: 17310016
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents.
    Saurenmann RK; Levin AV; Feldman BM; Laxer RM; Schneider R; Silverman ED
    J Pediatr; 2006 Dec; 149(6):833-6. PubMed ID: 17137902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment.
    Dinarello CA
    J Rheumatol Suppl; 2005 Mar; 74():40-7. PubMed ID: 15742464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
    J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract]   [Full Text] [Related]  

  • 10. TNFalpha blocker-induced thrombocytopenia.
    Pathare SK; Heycock C; Hamilton J
    Rheumatology (Oxford); 2006 Oct; 45(10):1313-4. PubMed ID: 16820379
    [No Abstract]   [Full Text] [Related]  

  • 11. Infectious complications of tumor necrosis factor-alpha antagonists.
    Bakleh M; Tleyjeh I; Matteson EL; Osmon DR; Berbari EF
    Int J Dermatol; 2005 Jun; 44(6):443-8. PubMed ID: 15941429
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on: Schnitzlers syndrome--exacerbation after anti-TNF treatment.
    de Koning HD; van der Meer JW; Simon A
    Rheumatology (Oxford); 2007 Nov; 46(11):1741 author reply 1741. PubMed ID: 17956920
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor necrosis factor inhibitor-induced pustular psoriasis?
    Heymann WR
    J Am Acad Dermatol; 2007 Feb; 56(2):327-9. PubMed ID: 17224374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study.
    Lim LL; Fraunfelder FW; Rosenbaum JT
    Arthritis Rheum; 2007 Oct; 56(10):3248-52. PubMed ID: 17907169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF- alpha inhibitors.
    Jackson JM
    Dermatol Ther; 2007; 20(4):251-64. PubMed ID: 17970890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schnitzler's syndrome--exacerbation after anti-TNF treatment.
    Thonhofer R; Uitz E; Graninger W
    Rheumatology (Oxford); 2007 Jun; 46(6):1041-2. PubMed ID: 17449490
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-TNF-alpha therapies: they are all the same (aren't they?).
    Mpofu S; Fatima F; Moots RJ
    Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
    Hyrich KL; Silman AJ
    J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
    [No Abstract]   [Full Text] [Related]  

  • 19. Both etanercept and infliximab can elevate tumor necrosis factor (TNF)-alpha and be the cause of treatment related new onset disease: the need to measure circulating TNF-alpha.
    Kast RE; Altschuler EL
    J Rheumatol; 2008 Aug; 35(8):1679; author reply 1679-80. PubMed ID: 18671327
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
    Gabriel SE
    Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.